CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Chief Business Officer acquired 1,368 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 2,018 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 846 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure
Page 6 of 74 · 1,467 filings